Get started
Work

The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia

Year: 2011
Type: article
Source: Leukemia
DOI: 10.1038/leu.2011.339
Authors: L Willems, N Chapuis, A Puissant, T T Maciel, A S Green, N Jacque, C Vignon, S Park, S Guichard, O Herault, A Fricot, O Hermine, I C Moura, P Auberger, N Ifrah, F Dreyfus, D Bonnet, C Lacombe, P Mayeux, D Bouscary, J Tamburini
Institutions: Centre National de la Recherche Scientifique, Institut Cochin, Université Paris Descartes, Inserm, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris, Centre Hospitalier Universitaire de Nice, Hôpital Charles-Nicolle, Université de Tours, Centre Hospitalier Universitaire de Tours, AstraZeneca (United Kingdom), Hôpital Necker-Enfants Malades, Hôpital Bretonneau, Centre Hospitalier Universitaire d'Angers, Cancer Research UK
Language: English
Open Access status: closed
OpenAlex ID: W2013003434
FWCI: 6.989
Cites: 47
Cited by: 159
Related to: 10